miR-181a/b-5p negatively regulates keratinocytes proliferation by targeting MELK

Mutian Niu1,2, Mingzhao Li1,2, Xiaomei Fan1,2

  • 1School of Intelligent Medicine and Biotechnology, Guilin Medical University, Guilin, 541199, Guangxi, P. R. China.

Insights

MicroRNAs miR-181a-5p and miR-181b-5p are downregulated in psoriasis and inhibit keratinocyte proliferation. These miRNAs target MELK, suggesting potential diagnostic and therapeutic roles in psoriasis.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Biochemistry

Background:

  • Psoriasis pathogenesis involves microRNAs (miRNAs).
  • Aberrant keratinocyte proliferation is a hallmark of psoriasis.
  • The specific roles of miR-181a-5p and miR-181b-5p in keratinocytes are not fully understood.

Purpose of the Study:

  • To investigate the involvement of miR-181a-5p and miR-181b-5p in HaCaT keratinocyte proliferation.
  • To elucidate the regulatory relationship between these miRNAs and Maternal Embryonic Leucine Zipper Kinase (MELK).

Main Methods:

  • Cell viability and proliferation assessed using CCK-8 and EdU assays.
  • Quantitative real-time PCR (qRT-PCR) and Western blotting for MELK and KRT16 expression.
  • Luciferase reporter assay to confirm miRNA-target interaction.

Main Results:

  • miR-181a-5p and miR-181b-5p expression was downregulated in psoriasis lesions.
  • These miRNAs negatively regulated HaCaT keratinocyte proliferation.
  • MELK was identified as a direct target of miR-181a-5p/miR-181b-5p.
  • MELK knockdown inhibited proliferation, while overexpression promoted it; miRNA mimics reversed MELK's effects.

Conclusions:

  • miR-181a-5p and miR-181b-5p negatively regulate keratinocyte proliferation by targeting MELK.
  • These miRNAs represent potential diagnostic biomarkers for psoriasis.
  • miR-181a-5p and miR-181b-5p offer potential therapeutic targets for psoriasis treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K